GENTING BHD

KLSE (MYR): GENTING (3182)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

4.62

Today's Change

-0.06 (1.28%)

Day's Change

4.62 - 4.69

Trading Volume

9,628,200

Financial

Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Date
Financial Result
Financial Ratio
Per Share Item
Performance
Valuation (End of Quarter)
Valuation (Ann. Date)
Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
39 people like this. Showing 50 of 80,587 comments

neohts

https://theedgemalaysia.com/node/707281

Genting Malaysia pledges US$1b in taxes to win New York City casino licence.

April 8): The owner of the Resorts World casino in New York City said an expansion of its gambling offering there would lift its tax payment to the state to more than US$1 billion (RM4.75 billion) annually.

Genting Malaysia Bhd, which operates the resort in Queens, is seeking one of the three new casino licences officials are considering for the New York City area. The property paid more than US$600 million in taxes last year, according to a spokesman for the casino giant.

Genting Malaysia is pledging to continue paying the state about 67% of its slot machine revenue in taxes, an amount that includes administrative fees and other expenses. The share paid for table games like blackjack would be lower, but enough to get the overall annual tax contribution over the US$1 billion mark.

Genting Malaysia, which operates next to the Aqueduct race track, and MGM Resorts International, which runs the Empire City Casino in Yonkers, are considered strong contenders, because they already have facilities there. The new licences would allow them to expand their offerings, including blackjack, roulette and other table games.
New York has some of the country’s highest casino taxes with an effective 55% rate on electronic devices, according to the American Gaming Association trade group. Casinos in Nevada — where Genting Malaysia has a Las Vegas resort — pay 6.8%.

4 days ago

neohts

https://www.nst.com.my/business/corporate/2024/03/1021303/maybank-ib-advises-investors-look-genting-given-its-involvement

Maybank IB advises investors to look at Genting given its involvement in life sciences

KUALA LUMPUR: Maybank Investment Bank (Maybank IB) is advising investors to explore opportunities in Genting Bhd's involvement in the life sciences sector via TauRx Pharmaceuticals Ltd.

This recommendation precedes TauRx Pharmaceuticals' unveiling of complete findings from its Phase 3 LUCIDITY trial of hydromethylthionine mesylate (HMTM), aimed at tackling Alzheimer's disease, scheduled for March 7.

"The company has started discussions with regulators in the UK and the US for product approval.

"In an optimistic scenario where the product is approved and TauRx is valued at US$15 billion with no discount, the target price for Genting could increase to RM9.40.

"Our estimates and RM5.73 target price remain the same, but we advise investors to buy now to position themselves early," it said.

However, TauRx claims that HMTM is effective in slowing cognitive decline and reducing brain atrophy, is safe without causing brain bleeding, and will be more affordable if approved because it can be taken orally instead of intravenously.

The life sciences company will present the 24-month data from its Phase 3 LUCIDITY trial of HMTM at the AD/PD 2024 Alzheimer's and Parkinson's Diseases Conference on March 7 in Lisbon, Portugal.

This presentation will include details of the final 12-month open-label phase of the trial, following the initial results reported throughout 2022.

Target price for Genting could increase to RM9.40.

4 days ago

stampid54

Got Raya rally this week for Genting? 😃

4 days ago

eagleye

TauRx will take a
Very
Long
Time
before getting US FDA approval.

IB's want to trap customers.
IBs can't be trusted.

IBs tell people to buy when they want to sell.
So, you chase to load up when they unload.
You end up trapped high up in the penthouse

IBs tell people to sell when they want to buy.
So, say neg news, people sell, IBs buy Low.

You'll tricked by IBs to buy Higher, sell Lower.
IBs Buy Lower, Sell Higher.

4 days ago

Ytl2023

Genting Singapore fly apa. Poh kong baru call flying

4 days ago

MG9231

@ micheal 志在必得!

4 days ago

keyman

50亿美元投资 换来一个全美国最高的博彩税率支付。还得和其他2个 casino强夺客源。这样的条件有啥好高兴的。真不懂... 有谁能解释下.... 😰

4 days ago

keyman

LimGE当时抽35%都被人骂到臭,还55%?Lkt脑子有病吧🤭有钱不派多点Div给我们,宁愿送美国佬?

4 days ago

keyman

No I could foreseen more kitchen sinking coming.... I quit first. 我劝你,别被人当傻子,还帮人数钱... 最后发现钱都是别人的🤭

4 days ago

choysun

Surely time for trend reversal, no?

4 days ago

neohts

Friday 19 April 2024 Dividend day.
One week later CEO and Directors all cash rich buy low and sell high again.

3 days ago

Marginofsatefy

On March 12, 2024 the FDA updated early Alzheimer’s drug development guidance to add support for biomarkers, surrogate endpoints. Timely development for TauRx.

Background

FDA is announcing the availability of a revised draft guidance for industry entitled “Early Alzheimer's Disease: Developing Drugs for Treatment.” This draft guidance is intended to assist sponsors in the clinical development of drugs for the treatment of the stages of sporadic AD that occur before the onset of overt dementia. This draft guidance revises the draft guidance for industry entitled “Early Alzheimer's Disease: Developing Drugs for Treatment” issued February 16, 2018 (83 FR 7060), and reflects FDA's consideration of public comments on the draft guidance. This revision describes FDA's current thinking regarding the use of biomarkers for the selection of participants with early stages of AD for enrollment in clinical trials, the selection of outcome measures for clinical trials in early AD, and the use of effects on characteristic pathophysiological changes of AD to support approval in these populations.

https://www.federalregister.gov/documents/2024/03/12/2024-05178/early-alzheimers-disease-developing-drugs-for-treatment-draft-guidance-for-industry-availability


A general section on outcome measures has been changed in the latest revision, now incorporating descriptions surrounding the use of co-primary endpoints and cognition originally found in the background section the 2018 draft guidance. The outcome measures section contains subsections describing clinical endpoints, time-to-event analysis, and surrogate endpoints.

“Sponsors considering the use of a biomarker as the primary measure of effect should discuss their plans with FDA early in development,” FDA wrote. “In general, even if accelerated approval is considered as the initial approval pathway, clinical outcome assessments should be included in clinical trials for early AD to assess early clinical changes that may potentially provide support for any changes observed on biomarkers.”

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/early-alzheimers-disease-developing-drugs-treatment

3 days ago

neohts

TauRX next action item ?
TauRX dateline for approval?
When?

2 days ago

OnTime

1 day ago

Johnchew123

Taufix aproval take 6 month proceed , Genting pi 4.50 to 4.60 go in buy n kept until QR May , QR May sure good , TP 5.40 after QR May announed , net profit guarantee increase , 2024 Feb , 1 month cuti + Chinese New Year cukup bring higher net profit , will reflect at QR MAY
TP 5.40 after QR May

1 day ago

neohts

Johnchew123
6 months I can wait.
Q1 results TP 5.40 ? Let 's pray hard hard. Good luck

1 day ago

Riaz1954

I am confident we will hear about regulatory approval of TauRx by August / September 2024. So worth remain invested in 2024….meanwhile take the dividends a they come. Not convinced about Genting business strategy though …willing to pay high taxes …….not many foreign companies make money in US particularly old business like gambling ….for boss it is ok as he can make money other way by dealing in shares and TP transactions etc

1 day ago

Michael_chan2022

Prices fluctuate.. up & down, up and down.., will they drop when investors leave in May? We know one thing is certain: Genting's next quarterly report should be promising

1 day ago

Michael_chan2022

How many people are in NYC in a day?
As of 2021, the population of New York City was estimated to be around 8.8 million people. This figure represents the residents of the city and does not account for daily fluctuations due to tourists, commuters, and other temporary visitors. Keep in mind that this number may have changed slightly since then.

1 day ago

Michael_chan2022

How many tourists visit New York state each year?
New York State also saw a 10% bump in visitation, with 291.5 million travelers compared to 266.7 million visitors in 2019. The year-over-year increases from 2021 to 2022 were overwhelming, with a 22% increase in visitation, over 50% gain in spending, and a more than 43% jump in economic impact.
13 Sept 2023

1 day ago

choysun

Opportunity strikes?

23 hours ago

neohts

https://www.nst.com.my/business/corporate/2024/04/1036993/genting-malaysia-strong-contender-new-york-city-new-casino

Genting Malaysia strong contender for New York City new casino license

22 hours ago

Gnanasong

Gaduh di Genting 😆 They lost their temper because they lost money?
https://www.malaysiakini.com/news/702285

21 hours ago

Michael_chan2022

https://www.cnbc.com/2024/04/11/european-central-bank-holds-interest-rates-hints-at-cut-ahead.html
European Central Bank gives strong signal that cuts are on the way despite Fed uncertainty

21 hours ago

hong

casino lottery gamble sector coming

21 hours ago

Michael_chan2022

https://youtu.be/ER-3hGjNoqA?si=eSk20EZb-jlkUFJZ
Something HUGE is happening in the oil markets

Plenty of growth opportunities for GenB..

21 hours ago

hong

Gamble sector coming

21 hours ago

yoonlee

RGB , LUSTER , GENTING

21 hours ago

keyman

@ Sifu michael.?? Really or not. 4.6x? If not mistaken, you did say that your average around 4.3x. Then your avg price higher then? 👍

20 hours ago

keyman

Sifu is a real Guru. Me cannot lah... Hold cash first.. 何必跟钱过不去

20 hours ago

Michael_chan2022

Of course, never follow others when ..investing

20 hours ago

Michael_chan2022

If my posts have influenced your decisions and emotions, it would be better for me to delete them

20 hours ago

Michael_chan2022

All investors have different situations.. many have amassed their fortunes in other stocks and are now investing in Genting. Never follow blindly..

20 hours ago

neohts

Let's wait until next Friday.
The best thing to do now is Don't do anything.

19 hours ago

Ytl2023

Holiday drop more. Apa share ini

18 hours ago

neohts

They push down the price so next week with dividend money they could buy more.
Then later they will push up even higher.

18 hours ago

prudentinvestor

Those who had heeded Maybank IB's advice and bought Genting about 5 weeks ago have all landed in Holland.

18 hours ago

hw0706

Genting who will replace the lim...

16 hours ago

neohts

AngTaykor the best person to replace lim
Too bad nobody have more share than lim.

15 hours ago

neohts

Getting 9 cents dividend losing 40 cents in share price.
WTF .....LKT

15 hours ago

choysun

Aiyo, you not losing 40 sens if you don't sell ma. Why worry, just let those who fear lose la :p

14 hours ago

AngTayKor

Posted by AngTayKor > 1 week ago | Report Abuse

@Choysun the 4.70 minor rebound look like over liow
------------

Already hinted price most likely will go lower. My short term market feel n punting skill is not too bad 😀😀

13 hours ago

AngTayKor

LKT is a veteran n shrewd biz man. I think overall he is ok as CEO, just that he will milk more for himself along the way (self interest first, its human nature la). ATK is just a hopeless punter that gambled showhand for Taurx investment luckily it turned out well 🙏

13 hours ago

eagleye

As always @AngTayKor astute and accurate.

12 hours ago

eagleye

There is no catalyst for GB to go up now.

Nxt QR pos growth & partly factored in alrdy.

RWNYC approval is the of END of 2025 !
Furthermore, DEBT WILL SHOOT UP.
Funding fr internal & external loans.

All GB sub pos growth nxt QR alrdy presumed

ONLY Taurx not presumed & factored in.
W/o Taurx, nothing to say & shout abt GB.

Many cos offer better div & cap appreciation

If Taurx breakthrough, all celebrate Cash !

12 hours ago

AngTayKor

Taurx could be a longer haul game, all depending on the corrupted FDA's decision on next yr Q3. Meanwhile those rights shares i bought has been compounding at over 100% annually over the last 2.5yrs. Im confident this compounding rate can continue on for another yr with UAE CA in Q4 this yr + deals waiting at sideline being activated after the first CA.

12 hours ago

snowball88

Sold for 4.94 a few weeks ago...then next day it close at 5.05 i think. was kicking myself but not so much now 😅. But i did sell it before the ex-date so basically 4.85.

10 hours ago

choysun

LKT seem to be more visible in the public now. Anything brewing? Hmm

3 hours ago

Post a Comment